Spirooxadiazoline-oxindoles derived from imatinib show antimyeloproliferative potential in K562 cells.
Article in Archiv der Pharmazie (April 2024)
The most recent citing publications are shown below. View all 39 publications that cite this research output on Dimensions.
Article in Archiv der Pharmazie (April 2024)
Article in Disease Markers (April 2024)
Book chapter (October 2023)